SARTORIUS AG-VORZUG (SRT3.DE) Fundamental Analysis & Valuation

FRA:SRT3 • DE0007165631

Current stock price

231.2 EUR
+3 (+1.31%)
Last:

This SRT3.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. SRT3.DE Profitability Analysis

1.1 Basic Checks

  • In the past year SRT3 was profitable.
  • In the past year SRT3 had a positive cash flow from operations.
  • SRT3 had positive earnings in each of the past 5 years.
  • SRT3 had a positive operating cash flow in each of the past 5 years.
SRT3.DE Yearly Net Income VS EBIT VS OCF VS FCFSRT3.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

1.2 Ratios

  • The Return On Assets of SRT3 (1.60%) is worse than 77.78% of its industry peers.
  • The Return On Equity of SRT3 (5.73%) is worse than 72.22% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 4.97%, SRT3 is doing worse than 77.78% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for SRT3 is below the industry average of 9.03%.
  • The last Return On Invested Capital (4.97%) for SRT3 is above the 3 year average (4.49%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.6%
ROE 5.73%
ROIC 4.97%
ROA(3y)1.51%
ROA(5y)3.97%
ROE(3y)6.23%
ROE(5y)15.62%
ROIC(3y)4.49%
ROIC(5y)9.01%
SRT3.DE Yearly ROA, ROE, ROICSRT3.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • Looking at the Profit Margin, with a value of 4.38%, SRT3 is doing worse than 72.22% of the companies in the same industry.
  • In the last couple of years the Profit Margin of SRT3 has declined.
  • SRT3 has a Operating Margin (15.34%) which is in line with its industry peers.
  • In the last couple of years the Operating Margin of SRT3 has declined.
  • SRT3 has a better Gross Margin (46.26%) than 66.67% of its industry peers.
  • SRT3's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 15.34%
PM (TTM) 4.38%
GM 46.26%
OM growth 3Y-16.16%
OM growth 5Y-5.98%
PM growth 3Y-35.4%
PM growth 5Y-13.41%
GM growth 3Y-3.93%
GM growth 5Y-2.18%
SRT3.DE Yearly Profit, Operating, Gross MarginsSRT3.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. SRT3.DE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SRT3 is destroying value.
  • Compared to 1 year ago, SRT3 has about the same amount of shares outstanding.
  • SRT3 has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for SRT3 has been reduced compared to a year ago.
SRT3.DE Yearly Shares OutstandingSRT3.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
SRT3.DE Yearly Total Debt VS Total AssetsSRT3.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • An Altman-Z score of 2.34 indicates that SRT3 is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • SRT3's Altman-Z score of 2.34 is on the low side compared to the rest of the industry. SRT3 is outperformed by 61.11% of its industry peers.
  • SRT3 has a debt to FCF ratio of 10.84. This is a negative value and a sign of low solvency as SRT3 would need 10.84 years to pay back of all of its debts.
  • SRT3 has a worse Debt to FCF ratio (10.84) than 66.67% of its industry peers.
  • SRT3 has a Debt/Equity ratio of 1.24. This is a high value indicating a heavy dependency on external financing.
  • With a Debt to Equity ratio value of 1.24, SRT3 is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.24
Debt/FCF 10.84
Altman-Z 2.34
ROIC/WACC0.64
WACC7.77%
SRT3.DE Yearly LT Debt VS Equity VS FCFSRT3.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.3 Liquidity

  • A Current Ratio of 0.90 indicates that SRT3 may have some problems paying its short term obligations.
  • SRT3's Current ratio of 0.90 is on the low side compared to the rest of the industry. SRT3 is outperformed by 83.33% of its industry peers.
  • A Quick Ratio of 0.50 indicates that SRT3 may have some problems paying its short term obligations.
  • SRT3 has a Quick ratio of 0.50. This is amonst the worse of the industry: SRT3 underperforms 88.89% of its industry peers.
Industry RankSector Rank
Current Ratio 0.9
Quick Ratio 0.5
SRT3.DE Yearly Current Assets VS Current LiabilitesSRT3.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. SRT3.DE Growth Analysis

3.1 Past

  • SRT3 shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 83.46%, which is quite impressive.
  • Measured over the past 5 years, SRT3 shows a small growth in Earnings Per Share. The EPS has been growing by 1.76% on average per year.
  • The Revenue has been growing slightly by 4.66% in the past year.
  • Measured over the past years, SRT3 shows a quite strong growth in Revenue. The Revenue has been growing by 8.66% on average per year.
EPS 1Y (TTM)83.46%
EPS 3Y-20.66%
EPS 5Y1.76%
EPS Q2Q%21.15%
Revenue 1Y (TTM)4.66%
Revenue growth 3Y-5.37%
Revenue growth 5Y8.66%
Sales Q2Q%2.29%

3.2 Future

  • The Earnings Per Share is expected to grow by 16.39% on average over the next years. This is quite good.
  • Based on estimates for the next years, SRT3 will show a quite strong growth in Revenue. The Revenue will grow by 8.94% on average per year.
EPS Next Y19.16%
EPS Next 2Y18.45%
EPS Next 3Y18.59%
EPS Next 5Y16.39%
Revenue Next Year6.1%
Revenue Next 2Y7.92%
Revenue Next 3Y8.69%
Revenue Next 5Y8.94%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
SRT3.DE Yearly Revenue VS EstimatesSRT3.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B
SRT3.DE Yearly EPS VS EstimatesSRT3.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

1

4. SRT3.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 48.37, SRT3 can be considered very expensive at the moment.
  • 83.33% of the companies in the same industry are cheaper than SRT3, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of SRT3 to the average of the S&P500 Index (27.38), we can say SRT3 is valued expensively.
  • SRT3 is valuated quite expensively with a Price/Forward Earnings ratio of 40.59.
  • Based on the Price/Forward Earnings ratio, SRT3 is valued a bit more expensive than the industry average as 77.78% of the companies are valued more cheaply.
  • SRT3 is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 38.20, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 48.37
Fwd PE 40.59
SRT3.DE Price Earnings VS Forward Price EarningsSRT3.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as SRT3.
  • SRT3's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 43.82
EV/EBITDA 21.61
SRT3.DE Per share dataSRT3.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • A more expensive valuation may be justified as SRT3's earnings are expected to grow with 18.59% in the coming years.
PEG (NY)2.52
PEG (5Y)27.43
EPS Next 2Y18.45%
EPS Next 3Y18.59%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. SRT3.DE Dividend Analysis

5.1 Amount

  • SRT3 has a yearly dividend return of 0.44%, which is pretty low.
  • SRT3's Dividend Yield is a higher than the industry average which is at 0.52.
  • With a Dividend Yield of 0.44, SRT3 pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.44%

5.2 History

  • On average, the dividend of SRT3 grows each year by 15.65%, which is quite nice.
Dividend Growth(5Y)15.65%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

  • SRT3 pays out 32.71% of its income as dividend. This is a sustainable payout ratio.
  • The dividend of SRT3 is growing around the same rate as the earnings are growing. If this keeps up the dividend growth is sustainable.
DP32.71%
EPS Next 2Y18.45%
EPS Next 3Y18.59%
SRT3.DE Yearly Income VS Free CF VS DividendSRT3.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
SRT3.DE Dividend Payout.SRT3.DE Dividend Payout, showing the Payout Ratio.SRT3.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

SRT3.DE Fundamentals: All Metrics, Ratios and Statistics

SARTORIUS AG-VORZUG

FRA:SRT3 (4/15/2026, 5:36:15 PM)

231.2

+3 (+1.31%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-03
Earnings (Next)04-23
Inst Owners1.97%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap17.31B
Revenue(TTM)3.54B
Net Income(TTM)155.00M
Analysts80
Price Target376.38 (62.79%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.44%
Yearly Dividend0.73
Dividend Growth(5Y)15.65%
DP32.71%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.19%
Min EPS beat(2)4.83%
Max EPS beat(2)7.55%
EPS beat(4)2
Avg EPS beat(4)-0.57%
Min EPS beat(4)-10.52%
Max EPS beat(4)7.55%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)0.53%
Min Revenue beat(2)0.24%
Max Revenue beat(2)0.83%
Revenue beat(4)3
Avg Revenue beat(4)0.75%
Min Revenue beat(4)-0.73%
Max Revenue beat(4)2.67%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.02%
PT rev (3m)8.39%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-2.19%
EPS NY rev (3m)-5.76%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.7%
Revenue NY rev (3m)-1.83%
Valuation
Industry RankSector Rank
PE 48.37
Fwd PE 40.59
P/S 4.89
P/FCF 43.82
P/OCF 20.68
P/B 6.4
P/tB N/A
EV/EBITDA 21.61
EPS(TTM)4.78
EY2.07%
EPS(NY)5.7
Fwd EY2.46%
FCF(TTM)5.28
FCFY2.28%
OCF(TTM)11.18
OCFY4.83%
SpS47.25
BVpS36.15
TBVpS-34.61
PEG (NY)2.52
PEG (5Y)27.43
Graham Number62.3508 (-73.03%)
Profitability
Industry RankSector Rank
ROA 1.6%
ROE 5.73%
ROCE 7%
ROIC 4.97%
ROICexc 5.35%
ROICexgc 20.27%
OM 15.34%
PM (TTM) 4.38%
GM 46.26%
FCFM 11.17%
ROA(3y)1.51%
ROA(5y)3.97%
ROE(3y)6.23%
ROE(5y)15.62%
ROIC(3y)4.49%
ROIC(5y)9.01%
ROICexc(3y)4.83%
ROICexc(5y)9.64%
ROICexgc(3y)16.7%
ROICexgc(5y)28.15%
ROCE(3y)6.33%
ROCE(5y)12.7%
ROICexgc growth 3Y-19.62%
ROICexgc growth 5Y-7.23%
ROICexc growth 3Y-29.84%
ROICexc growth 5Y-12.08%
OM growth 3Y-16.16%
OM growth 5Y-5.98%
PM growth 3Y-35.4%
PM growth 5Y-13.41%
GM growth 3Y-3.93%
GM growth 5Y-2.18%
F-Score7
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 1.24
Debt/FCF 10.84
Debt/EBITDA 3.49
Cap/Depr 105.19%
Cap/Sales 12.49%
Interest Coverage 3
Cash Conversion 86.94%
Profit Quality 254.9%
Current Ratio 0.9
Quick Ratio 0.5
Altman-Z 2.34
F-Score7
WACC7.77%
ROIC/WACC0.64
Cap/Depr(3y)122.42%
Cap/Depr(5y)145.08%
Cap/Sales(3y)13.7%
Cap/Sales(5y)13.08%
Profit Quality(3y)357.39%
Profit Quality(5y)249.46%
High Growth Momentum
Growth
EPS 1Y (TTM)83.46%
EPS 3Y-20.66%
EPS 5Y1.76%
EPS Q2Q%21.15%
EPS Next Y19.16%
EPS Next 2Y18.45%
EPS Next 3Y18.59%
EPS Next 5Y16.39%
Revenue 1Y (TTM)4.66%
Revenue growth 3Y-5.37%
Revenue growth 5Y8.66%
Sales Q2Q%2.29%
Revenue Next Year6.1%
Revenue Next 2Y7.92%
Revenue Next 3Y8.69%
Revenue Next 5Y8.94%
EBIT growth 1Y38.38%
EBIT growth 3Y-20.66%
EBIT growth 5Y2.17%
EBIT Next Year81.03%
EBIT Next 3Y32.63%
EBIT Next 5Y24.23%
FCF growth 1Y-30.23%
FCF growth 3Y23.14%
FCF growth 5Y7.81%
OCF growth 1Y-14.26%
OCF growth 3Y4.46%
OCF growth 5Y10.35%

SARTORIUS AG-VORZUG / SRT3.DE Fundamental Analysis FAQ

What is the ChartMill fundamental rating of SARTORIUS AG-VORZUG (SRT3.DE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to SRT3.DE.


Can you provide the valuation status for SARTORIUS AG-VORZUG?

ChartMill assigns a valuation rating of 1 / 10 to SARTORIUS AG-VORZUG (SRT3.DE). This can be considered as Overvalued.


What is the profitability of SRT3 stock?

SARTORIUS AG-VORZUG (SRT3.DE) has a profitability rating of 3 / 10.


Can you provide the expected EPS growth for SRT3 stock?

The Earnings per Share (EPS) of SARTORIUS AG-VORZUG (SRT3.DE) is expected to grow by 19.16% in the next year.


Can you provide the dividend sustainability for SRT3 stock?

The dividend rating of SARTORIUS AG-VORZUG (SRT3.DE) is 4 / 10 and the dividend payout ratio is 32.71%.